Metropolitan Life Insurance Company (MetLife)’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,455
| Closed | -$99K | – | 2610 |
|
|
2020
Q3 | $99K | Buy |
5,455
+543
| +11% | +$9.85K | ﹤0.01% | 2223 |
|
|
2020
Q2 | $67.3K | Hold |
4,912
| – | – | ﹤0.01% | 2455 |
|
|
2020
Q1 | $70.2K | Sell |
4,912
-96
| -2% | -$1.37K | ﹤0.01% | 2248 |
|
|
2019
Q4 | $84.8K | Hold |
5,008
| – | – | ﹤0.01% | 2416 |
|
|
2019
Q3 | $77.1K | Hold |
5,008
| – | – | ﹤0.01% | 2439 |
|
|
2019
Q2 | $117K | Hold |
5,008
| – | – | ﹤0.01% | 2222 |
|
|
2019
Q1 | $142K | Hold |
5,008
| – | – | ﹤0.01% | 2116 |
|
|
2018
Q4 | $151K | Hold |
5,008
| – | – | ﹤0.01% | 2003 |
|
|
2018
Q3 | $175K | Buy |
+5,008
| New | +$175K | ﹤0.01% | 2086 |
|
|
2018
Q2 | – | Sell |
-5,008
| Closed | -$128K | – | 2515 |
|
|
2018
Q1 | $128K | Sell |
5,008
-610
| -11% | -$15.6K | ﹤0.01% | 2165 |
|
|
2017
Q4 | $98K | Sell |
5,618
-10,911
| -66% | -$190K | ﹤0.01% | 2322 |
|
|
2017
Q3 | $457K | Buy |
+16,529
| New | +$457K | ﹤0.01% | 1749 |
|